Episode 11.10 New Guidelines For Cervical Cancer Screening and More!
Impossibile aggiungere al carrello
Rimozione dalla Lista desideri non riuscita.
Non è stato possibile aggiungere il titolo alla Libreria
Non è stato possibile seguire il Podcast
Esecuzione del comando Non seguire più non riuscita
Episode 11.10 New Guidelines For Cervical Cancer Screening and More!
-
Letto da:
-
Di:
A proposito di questo titolo
We bring back the biggest takeaways from the ACOG ACSM, then move fast through the newest guidance and the newest hype shaping real OBGYN care. We focus on what the evidence actually supports, where practice still lags behind, and how “labels” can quietly push patients toward harm.
• conference highlights including rural OBGYN access and what gets attention on the exhibit floor
• vitamin K shot refusal trends and why late bleeding still matters weeks after birth
• 2026 ACOG cervical cancer screening changes with primary HPV testing preferred for ages 30 to 65
• self-collected HPV screening and the systems needed to keep follow-up safe
• why annual Pap testing and cytology-only strategies increase overdiagnosis and can miss HPV risk
• postmenopausal bleeding workup shifting toward ultrasound plus endometrial biopsy up front
• large baby induction data and why outcomes can worsen without neonatal benefit
• third-trimester ultrasound screening performance and the real-world labeling effect
• early proof-of-concept therapy for preeclampsia targeting sFlt1 removal to prolong pregnancy
• hysterectomy duration and route as drivers of venous thromboembolism risk
• laboring down claims from retrospective reports versus randomized trial findings
• debunking physiologic third stage claims and reaffirming active management to prevent hemorrhage
Be sure to check out thinkingaboutobgyn.com for more information, and be sure to follow us on Instagram.
0:00 ACOG Meeting Takeaways And Rural Access
3:58 Vitamin K Refusal And Newborn Bleeding
6:37 Cervical Screening Moves Toward HPV
14:48 Postmenopausal Bleeding Now Needs Biopsy
20:00 Tylenol Data And Macrosomia Induction
28:34 Ultrasound Labeling Effect And Liability Fears
37:29 Removing sFlt1 To Buy Time
40:14 Longer Hysterectomy Surgeries Raise VTE Risk
42:14 Laboring Down Claims Versus RCT Reality
49:59 Counseling Fatigue Without Ignoring Risk
54:21 Third Stage Myths And Hemorrhage Prevention
58:42 Evidence Literacy And Closing Notes
Follow us on Instagram @thinkingaboutobgyn.